Literature DB >> 7835978

Effect of C1q on the processing of immune complexes by human neutrophils.

M Ohkuro1, K Kobayashi, K Takahashi, S Nagasawa.   

Abstract

We prepared immune complexes (IC) composed of human anti-tetanus toxoid IgG and tetanus toxoid, and examined the effect of C1q on the processing of IC by human neutrophils. Treating IC with increasing amounts of C1q enhanced the binding and phagocytosis of IC by neutrophils, unless the amounts of C1q added were less than those required to saturate the C1q binding sites of IC. With the increase of unbound excess C1q, the IC processing by neutrophils decreased. Superoxide anions generated during the processing of IC-C1q were entrapped in phagosomes and were not released from neutrophils. The C1q-dependent inhibition of IC processing by neutrophils was not observed when C1q-treated neutrophils were washed and allowed to react with IC, suggesting that the inhibition by excess C1q is due to the hindrance of IC-C1q binding to neutrophils by loosely bound C1q on neutrophils. The C1q-treated, washed neutrophils still showed enhanced responses to IC, suggesting that free C1q as well as the IC-C1q complex can prime neutrophils to enhance Fc receptor (FcR)-mediated cellular responses. Thus, C1q may have two effects on the processing of IC by neutrophils; firstly, it enhances FcR-mediated cellular responses, and secondly, it prevents superoxide anion-induced tissue damage by trapping superoxide anions in phagosomes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835978      PMCID: PMC1415047     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Active disassembly of the first complement component, C-1, by C-1 inactivator.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

3.  Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component.

Authors:  A J Tenner; N R Cooper
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

4.  The role of immune complexes in the activation of the first component of human complement.

Authors:  R J Ziccardi
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  Direct demonstration and quantitation of the first complement component in human serum.

Authors:  R J Ziccardi; N R Cooper
Journal:  Science       Date:  1978-03-10       Impact factor: 47.728

6.  Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells.

Authors:  A J Tenner; N R Cooper
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

7.  Complete amino acid sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement.

Authors:  K B Reid
Journal:  Biochem J       Date:  1979-05-01       Impact factor: 3.857

8.  Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.

Authors:  D A Bobak; M M Frank; A J Tenner
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

9.  Signal transduction mechanisms of C1q-mediated superoxide production. Evidence for the involvement of temporally distinct staurosporine-insensitive and sensitive pathways.

Authors:  E B Goodman; A J Tenner
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

10.  Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils.

Authors:  R J Looney; D H Ryan; K Takahashi; H B Fleit; H J Cohen; G N Abraham; C L Anderson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  1 in total

1.  Release of calreticulin from neutrophils may alter C1q-mediated immune functions.

Authors:  U Kishore; R D Sontheimer; K N Sastry; K S Zaner; E G Zappi; G R Hughes; M A Khamashta; P Strong; K B Reid; P Eggleton
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.